1.17
price down icon1.68%   -0.02
after-market Handel nachbörslich: 1.18 0.01 +0.85%
loading

Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten

pulisher
Jul 17, 2025

Financial Review: Ainos (NASDAQ:AIMD) vs. Pyxis Oncology (NASDAQ:PYXS) - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

what makes pyxis oncology inc. stock price move sharplyGrowth Optimized Stock Radar - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Pyxis Oncology Inc. stock performs during market volatilityDaily Trade Opportunity - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Pyxis Oncology Inc. stock price move sharplyDaily Volume Leaders - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Average Price Target from Analysts - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

Pyxis Oncology (NASDAQ:PYXS) Stock Price Up 3.6% – Time to Buy? - Defense World

Jul 08, 2025
pulisher
Jul 04, 2025

Pyxis Oncology Appoints New Principal Financial Officer - The Globe and Mail

Jul 04, 2025
pulisher
Jul 03, 2025

Pyxis Oncology announces retirement of CFO and COO Pamela Connealy By Investing.com - Investing.com South Africa

Jul 03, 2025
pulisher
Jul 03, 2025

Pyxis Oncology, Inc. Announces CFO Changes, Effective July 1, 2025 - MarketScreener

Jul 03, 2025
pulisher
Jun 30, 2025

Pyxis Oncology's Equity Incentives: A Strategic Gambit for Clinical Success? - AInvest

Jun 30, 2025
pulisher
Jun 30, 2025

Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 2000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

Pyxis Oncology Inc (PYXS) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jun 27, 2025
pulisher
Jun 18, 2025

Pyxis Oncology shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Pyxis Oncology Elects New Directors at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 16, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Takes $35,000 Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Grows Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Cuts Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Sold by Deutsche Bank AG - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 05, 2025
pulisher
May 31, 2025

Northern Trust Corp Sells 15,449 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 31, 2025
pulisher
May 30, 2025

Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments - TipRanks

May 30, 2025
pulisher
May 29, 2025

Millennium Management LLC Has $4.65 Million Stock Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 29, 2025
pulisher
May 25, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Consensus PT from Analysts - Defense World

May 25, 2025
pulisher
May 22, 2025

HC Wainwright Weighs in on Pyxis Oncology Q1 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 EPS Estimates for Pyxis Oncology Cut by HC Wainwright - Defense World

May 22, 2025
pulisher
May 20, 2025

Leerink Partnrs Comments on Pyxis Oncology FY2029 Earnings - Defense World

May 20, 2025
pulisher
May 20, 2025

Pyxis Oncology’s (PYXS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Pyxis Oncology (PYXS) Receives Reiterated Buy Rating from Analys - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Raises Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 18, 2025
pulisher
May 16, 2025

Pyxis Oncology : May 2025 Corporate Deck (9474da) - marketscreener.com

May 16, 2025
pulisher
May 15, 2025

Pyxis Oncology Reports Q1 Loss and Business Update - TipRanks

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology (PYXS) Advances Cancer Treatment Research | PYXS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology : May 2025 Corporate Deck (c8a9bd) - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Purchases 12,924 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 15, 2025
pulisher
May 14, 2025

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Pyxis Oncology, Inc. CEO Lara S. Sullivan to Participate in Upcoming Investor Conferences - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Next-Gen Cancer Drug Developer Pyxis Oncology Sets Major Investor Conference Schedule for May-June - Stock Titan

May 14, 2025
pulisher
May 11, 2025

Pyxis Oncology (PYXS) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 07, 2025

New Approaches to Tumor Targeting Are Driving the Next Wave of Oncology Breakthroughs - Baystreet.ca

May 07, 2025
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
Kapitalisierung:     |  Volumen (24h):